Literature DB >> 8496130

The Diagnostic Interview Schedule for Children-Revised Version (DISC-R): III. Concurrent criterion validity.

J Piacentini1, D Shaffer, P Fisher, M Schwab-Stone, M Davies, P Gioia.   

Abstract

OBJECTIVE: To examine the concurrent criterion validity of the Revised Diagnostic Interview Schedule for Children (DISC-R), a structured lay-administered instrument designed for use in community studies, under conditions designed to provide strict controls for information and method variance.
METHOD: The DISC-R was compared with a semistructured clinical interview that covered a similar information base as the DISC-R, used standardized ratings to record symptom information, and, similar to the DISC-R, was scored by DSM-III-R-based computerized diagnostic algorithms. Subjects were 74 child and adolescent clinic attendees and their adult custodians.
RESULTS: Overall, moderate levels of agreement were found between DISC-R and clinician-generated diagnoses; these findings were tempered, however, by the fact that the validation interview was less reliable than the DISC-R.
CONCLUSIONS: Although these findings provide preliminary support for the use of the DISC-R, they cast some doubt on the adequacy of clinician-generated diagnoses as validation criteria and suggest that alternate approaches to the assessment of validation should be pursued.

Entities:  

Mesh:

Year:  1993        PMID: 8496130     DOI: 10.1097/00004583-199305000-00025

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  48 in total

1.  Help-seeking steps and service use for children in foster care.

Authors:  B T Zima; R Bussing; X Yang; T R Belin
Journal:  J Behav Health Serv Res       Date:  2000-08       Impact factor: 1.505

2.  Racial/ethnic differences in the use of psychotropic medication in high-risk children and adolescents.

Authors:  Laurel K Leslie; Jill Weckerly; John Landsverk; Richard L Hough; Michael S Hurlburt; Patricia A Wood
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-12       Impact factor: 8.829

Review 3.  Comorbidity and child psychopathology: recommendations for the next decade.

Authors:  Peter S Jensen
Journal:  J Abnorm Child Psychol       Date:  2003-06

4.  Temporal relations in daily-reported maternal mood and disruptive child behavior.

Authors:  Frank J Elgar; Daniel A Waschbusch; Patrick J McGrath; Sherry H Stewart; Lori J Curtis
Journal:  J Abnorm Child Psychol       Date:  2004-06

5.  Relapse Contexts for Substance Abusing Adolescents with Comorbid Psychopathology.

Authors:  Kristen G Anderson; Kevin C Frissell; Sandra A Brown
Journal:  J Child Adolesc Subst Abuse       Date:  2007

6.  Child sociodemographic characteristics and common psychiatric diagnoses in medicaid encounter data: are they valid?

Authors:  Penelope K Knapp; Michael S Hurlburt; Eric C Kostello; Heather Ladd; Lingqi Tang; Bonnie T Zima
Journal:  J Behav Health Serv Res       Date:  2006-10       Impact factor: 1.505

7.  Loss Due to Death and its Association with Mental Disorders in Juvenile Detainees.

Authors:  Julie Laken Harnisher; Karen Abram; Jason Washburn; Marquita Stokes; Nicole Azores-Gococo; Linda Teplin
Journal:  Juv Fam Court J       Date:  2015

8.  Substance use treatment outcomes for youth: integrating personal and environmental predictors.

Authors:  Kristen G Anderson; Danielle E Ramo; Marya T Schulte; Kevin Cummins; Sandra A Brown
Journal:  Drug Alcohol Depend       Date:  2006-11-07       Impact factor: 4.492

9.  Effectiveness of multidimensional family therapy with higher severity substance-abusing adolescents: report from two randomized controlled trials.

Authors:  Craig E Henderson; Gayle A Dakof; Paul E Greenbaum; Howard A Liddle
Journal:  J Consult Clin Psychol       Date:  2010-12

10.  Multiple substance use disorders in juvenile detainees.

Authors:  Gary M McClelland; Katherine S Elkington; Linda A Teplin; Karen M Abram
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-10       Impact factor: 8.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.